Latest Stories
HP (NYSE:HPQ) Exceeds Q4 CY2025 Expectations But Stock Drops
Personal computing and printing company HP (NYSE:HPQ) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.9% year on year to $14.44 billion. Its non-GAAP profit of $0.81 per share was 5.3% above analysts’ consensus estimates.
CAVA’s (NYSE:CAVA) Q4 CY2025 Sales Top Estimates, Stock Soars
Mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 20.9% year on year to $275 million. Its GAAP profit of $0.04 per share was $0.01 above analysts’ consensus estimates.
Revolve (NYSE:RVLV) Delivers Strong Q4 CY2025 Numbers
Online fashion retailer Revolve (NASDAQ:RVLV) announced better-than-expected revenue in Q4 CY2025, with sales up 10.4% year on year to $324.4 million. Its GAAP profit of $0.26 per share was 57.8% above analysts’ consensus estimates.
Marqeta (NASDAQ:MQ) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops
Payment technology company Marqeta (NASDAQ:MQ) announced better-than-expected revenue in Q4 CY2025, with sales up 26.7% year on year to $172.1 million. The company expects next quarter’s revenue to be around $164.1 million, close to analysts’ estimates. Its GAAP loss of $0 per share was $0.01 above analysts’ consensus estimates.
Workday (NASDAQ:WDAY) Reports Q4 CY2025 In Line With Expectations But Stock Drops
Enterprise software company Workday (NASDAQ:WDAY) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 14.5% year on year to $2.53 billion. Its non-GAAP profit of $2.47 per share was 6.4% above analysts’ consensus estimates.
Flywire (NASDAQ:FLYW) Beats Expectations in Strong Q4 CY2025, Stock Jumps 11.9%
Global payments company Flywire (NASDAQ:FLYW) announced better-than-expected revenue in Q4 CY2025, with sales up 39.7% year on year to $157.5 million. Its GAAP loss of $0 per share was $0.01 above analysts’ consensus estimates.
Boston Beer (NYSE:SAM) Reports Q4 CY2025 In Line With Expectations
Beer company Boston Beer (NYSE:SAM) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 4.1% year on year to $385.7 million. Its GAAP loss of $2.12 per share was 15.3% above analysts’ consensus estimates.
Zeta Global (NYSE:ZETA) Delivers Impressive Q4 CY2025, Growth To Accelerate Next Year
Marketing technology company Zeta Global (NYSE:ZETA) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 25.4% year on year to $394.6 million. Guidance for next quarter’s revenue was optimistic at $370 million at the midpoint, 2.1% above analysts’ estimates.
Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q4 CY2025: Strong Sales
Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 21.5% year on year to $211.6 million. On the other hand, the company’s full-year revenue guidance of $855 million at the midpoint came in 0.7% below analysts’ estimates. Its GAAP loss of $0.07 per share was 66.7% above analysts’ consensus estimates.
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.1% year on year to $1.20 billion. On the other hand, the company’s full-year revenue guidance of $4.38 billion at the midpoint came in 2.8% below analysts’ estimates. Its non-GAAP profit of $6.64 per share was 2.1% above analysts’ consensus estimates.